Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-29T22:22:33.643Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunogenicity of experimental trachoma vaccines in baboons: II. Experiments with adjuvants, and tests of cross-protesction

Published online by Cambridge University Press:  15 May 2009

L. H. Collier  and
W. A. Blyth
L. H. Collier
Affiliation:
Medical Research Council Trachoma Research Unit, Lister Institute of Preventive Medicine, London, S. W. 1
W. A. Blyth
Affiliation:
Medical Research Council Trachoma Research Unit, Lister Institute of Preventive Medicine, London, S. W. 1
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A mineral oil adjuvant failed to enhance or to prolong the somewhat shortlived immunity induced in baboons by trachoma/inclusion conjunctivitis (TRIC) vaccines, and was of little or no value in increasing or prolonging the formation of group complement-fixing (CF) antibody. Vaccines prepared with protamine sulphate or with calcium phosphate were no more immunogenic than the untreated parent suspensions.

Cross tests with aqueous vaccines revealed antigenic differences in the TRIC agents examined, in terms of their ability to protect against conjunctival challenge. Strain MRC–1/OT differed from MRC–17 and from MRC–4, and MRC–187 from MRC–4f.

The four Gambian trachoma agents tested were much less effective than the MRC–4 strain of inclusion conjunctivitis in inducing group CF antibody in baboons. The titre of circulating antibody bore no relation to the state of immunity to conjunctival challenge.

In three baboons given mineral oil adjuvant vaccine and in one given aqueous vaccine the conjunctival responses to subsequent challenge were significantly enhanced. This reaction may be an expression of a hypersensitive state induced by relatively ineffective vaccines; like immunity, it is unrelated to the titre of CF antibody in the serum.

Type
Research Article
Information
Journal of Hygiene , Volume 64 , Issue 4 , December 1966 , pp. 529 - 544
Copyright
Copyright © Cambridge University Press 1966

References

REFERENCES

Bell, S. D. & Theobald, B. (1962). Differentiation of trachoma strains on the basis of immunization against toxic death of mice. Ann. N. Y. Acad. Sci. 98, 337.CrossRefGoogle ScholarPubMed
Bietti, G. B. (1964). Profilassi e terapia delle malattie oculari con particulare riguardo al tracoma. Atti dello Convegno Nazionale de ‘Oftalrnologia Sociale’, 05, pp. 170–91. Naples.Google Scholar
Bovabnick, M. R., Miller, J. C. & Snyder, J. C. (1950). The influence of certain salts, amino acids, sugars and proteins on the stability of riekettsiae. J. Bact. 59, 509.CrossRefGoogle Scholar
Chambers, L. A. & Henle, W. (1941). Precipitation of active influenza A virus from extra-embryonic fluids by protamine. Proc. Soc. exp. Biol. Med. 48, 481.CrossRefGoogle Scholar
Collier, L. H. (1961). Experiments with trachoma vaccines: experimental system using inclusion blennorrhoea virus. Lancet, i, 795.CrossRefGoogle Scholar
Collier, L. H. (1962). Experimental infection of baboons with inclusion blennorrhoea and trachoma. Ann. N.Y. Acad. Sci. 98, 188.CrossRefGoogle ScholarPubMed
Collier, L. H. & Blyth, W. A. (1966). Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J. Hyg., Camb. 64, 513.Google ScholarPubMed
Collier, L. H. & Sowa, J. (1958). Isolation of trachoma virus in embryonate eggs. Lancet, i, 993.CrossRefGoogle Scholar
Dulbecco, R. & Vogt, M. (1954). Plaque formation and isolation of pure lines with poliomyelitis viruses. J. exp. Med. 99, 167.CrossRefGoogle ScholarPubMed
Grayston, J. T. (1963). Biology of the virus. In Symposium on Trachoma. Invest. Ophthal. 2, 460.Google ScholarPubMed
Grayston, J. T., Wang, S. P., Woolridge, R. L. & Alexander, E. R. (1964). Prevention of trachoma with vaccine. Archs envir. Hlth 8, 518.CrossRefGoogle ScholarPubMed
Grayston, J. T., Woolridge, R. L. & Wang, S. P. (1962). Trachoma vaccine studies in Taiwan. Ann. N.Y. Acad. Sci. 98, 352.CrossRefGoogle Scholar
Hanna, L. & Bernkopf, H. (1964). Trachoma viruses isolated in the United States. VIII. Separation of TRIC viruses from related agents by immunofluorescence. Proc. Soc. exp. Biol. Med. 116, 827.CrossRefGoogle Scholar
Khaw, O. K., Lin, H. M., Wang, S. P., Woolridge, R. L. & Grayston, J. T. (1963). Trachoma vaccine studies in volunteer students of the National Defense Medical Center. III. Oil adjuvant vaccine: antibody response study and eye challenge inoculation with egg grown and purified trachoma virus. Chin. med. J. free China Edn 10, 97.Google Scholar
Nichols, R. L. & McComb, D. E. (1964). Serologic strain differentiation in trachoma. J. exp. Med. 120, 639.CrossRefGoogle ScholarPubMed
Reeve, P. & Taverne, J. (1963). Observations on the growth of trachoma and inclusion blennorrhoea viruses in embryonate eggs. J. Hyg., Camb. 61, 67.CrossRefGoogle Scholar
Snyder, J. C., Nichols, R. L., Bell, S. D., Haddad, N. A., Murray, E. S. & McComb, D. E. (1964). Vaccination against trachoma in Saudi Arabia: design of field trials and initial results. Industry trop. Hlth 5, 65.Google Scholar
Sowa, J. & Collier, L. H. (1960). Isolation of trachoma virus from patients in West Africa. J. Hyg., Camb. 58, 99.CrossRefGoogle ScholarPubMed
Taverne, J., Marshall, J. H. & Fulton, F. (1958). The purification and concentration of viruses and virus soluble antigens on calcium phosphate. J. gen. Microbiol. 19, 451.CrossRefGoogle ScholarPubMed
Tiselius, A., Hjebtén, S. & Levin, Ö. (1956). Protein chromatography on calcium phosphate columns. Archs Biochem. Biophys. 65, 132.CrossRefGoogle Scholar
Wang, S. P. & Grayston, J. T. (1963). Classification of trachoma virus strains by protection of mice from toxic death. J. Immun. 90, 849.CrossRefGoogle ScholarPubMed